SAVA
FILANA THERAPEUTICS, INC.Former ticker of FILANA THERAPEUTICS, INC. · FLNA stock page →
No price
Median target
$8.00
range $8.00–8.00
Price
Daily candles with volume.
No data for this timeframe.
The Street
Last action Oct 2025Recent actions
| Date | Firm | Rating |
|---|---|---|
| Oct 6, 2025 | LUCID CAPITAL MARKETS INITIATE | Buy |
| Mar 25, 2025 | HC Wainwright & Co. REITERATE | Neutral |
| Mar 4, 2025 | HC Wainwright & Co. REITERATE | Neutral |
| Nov 26, 2024 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Nov 8, 2024 | HC Wainwright & Co. REITERATE | Buy |
| Oct 8, 2024 | HC Wainwright & Co. UPGRADE | Buy |
Earnings setup
Estimates−$0.30
EPS estimate, this quarter
Current-quarter EPS estimate
$0.00090d
$0.00060d
−$0.27030d
−$0.2707d
−$0.300Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Next Q | -$0.31 | -$0.31–-$0.31 | -3.3% | $0.00 |
| Current FY | -$1.93 | -$1.93–-$1.93 | +0.0% | $0.00 |
| Current Q | -$0.30 | -$0.30–-$0.30 | -11.1% | $0.00 |
| Next FY | -$1.22 | -$1.22–-$1.22 | -5.2% | $0.00 |
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Mar 3, 2026 Earnings calendar
SAVA Q4 2025 Earnings After Market Close, 2026-03-03
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent